rs794728947
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003000.3(SDHB):c.210dupC(p.Met71HisfsTer10) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003000.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Pheochromocytoma;C0238198:Gastrointestinal stromal tumor;C1861848:Paragangliomas 4 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Met71Hisfs*10) in the SDHB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHB are known to be pathogenic (PMID: 19454582, 19802898). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with head and neck paragangliomas (PMID: 11897817). This variant is also known as c.207–210insC (p.M71fsX80). ClinVar contains an entry for this variant (Variation ID: 201604). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The c.210dupC mutation in the SDHB gene causes a frameshift starting with codon Methionine 71, changes this amino acid to a Histidine residue and creates a premature Stop codon at position 10 of the new reading frame, denoted p.Met71HisfsX10. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is found in the SDHB panel(s). -
Paragangliomas 4 Pathogenic:1
This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.210dupC pathogenic mutation, located in coding exon 3 of the SDHB gene, results from a duplication of C at nucleotide position 210, causing a translational frameshift with a predicted alternate stop codon. This alteration was reported (as c.207_210insC) in 1/55 individuals with head and neck cancers, and segregated with disease in two individuals in that family (Baysal BE et al. J. Med. Genet. 2002 Mar;39(3):178-83). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at